- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05502055
Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+ (LGBTQ+_PD)
Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as Lesbian, Gay, Bisexual, Transgender, Questioning, Intersex, or Two-spirit
Study Rationale:
Older adults who identify as lesbian, gay, bisexual, transgender, or queer (LGBTQ+) have worse health than non-LGBTQ+ older adults. They and their care partners face greater barriers to getting healthcare and support from friends and family. This is because of lifelong stigma, discrimination, and isolation often separated from their families. Parkinson disease (PD) is a disease that usually appears in older age, so there may be many LGBTQ+ elders with PD, but there is currently no information on how people with PD who are LGBTQ+ are coping with their disease and aging. This study will begin to clarify their needs.
Hypothesis/Research Question:
What are the experiences and perspectives of LGBTQ+ people living with PD, their care partners, and physicians managing people with PD?
Study Design:
The investigators will interview 20 people with PD, half who identify as LGBTQ+ and half who are not. The investigators will also interview their care partners and physicians who treat people with PD. From the responses to the interview questions, investigators will create a survey that will be sent to people across the country.
Impact on Diagnosis/Treatment of Parkinson's Disease:
By understanding what LGBTQ+ people with PD need, and what ideas they have for improving their healthcare, better systems for meeting their needs can be built.
Next Steps for Development:
With this understanding, future work can focus on educating healthcare providers and clinics to improve the ways they talk with and treat LGBTQ+ people with PD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This mixed-methods study has a qualitative study component (1) and a quantitative study component (2):
Component 1) using a phenomenological inductive approach and Grounded Theory methodology the investigators will find and build themes from semi-structured interviews and focus groups with a) LGBTQ+ and non-LGBTQ+ individuals with PD, b) their care partners, and c) physicians to identify the experiences and perspectives on their health care and participation in research.
Component 2) survey development informed by results of Component 1, national distribution, and analysis of LGBTQ+ and non-LGBTQ+ people with PD, their caregivers and physicians, on barriers and access to health and disease information, healthcare delivery and participation in research.
The investigators plan to recruit 10 LGBTQ+ individuals with PD, 10 Non-LGBTQ+ individuals with PD, 10 care partners, and 10 healthcare providers for individual interviews, and 50 LGBTQ+ older adults with PD and care partners for focus groups consisting of 6-8 individuals each. For the national electronic survey investigators estimate needing a the sample size of approximately 380 responses calculated using a 95% confidence level (Z score=1.96), a standard deviation of .5, a 5% margin of error, and a population of 30,000. Purposive and Snowball sampling methods (nonprobability sampling) will be used.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Tara L McIsaac, PT, PhD
- Phone Number: 602-812-4582
- Email: TaraMcIsaac@creighton.edu
Study Contact Backup
- Name: Katy Sutton, DPT PhD MPH
- Email: KatySutton@creighton.edu
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85012
- Recruiting
- Creighton University Phoenix
-
Contact:
- Tara L McIsaac, PT, PhD
- Phone Number: 602-812-4582
- Email: TaraMcIsaac@creighton.edu
-
Contact:
- Katy Sutton, DPT PhD MPH
- Email: KatySutton@creighton.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosed with PD
- Care partner of someone diagnosed with PD
- Health Care Provider providing services to individuals with PD
- Identify as LGBTQ+
- Identify as Non-LGBTQ+
Exclusion Criteria:
- Non-English speaking
- Inability to communicate via video conferencing
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
LGBTQ+_PD
Individuals who identify as LGBTQ+ and are diagnosed with PD
|
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
|
Non-LGBTQ_PD
Individuals who identify as non-LGBTQ+ and are diagnosed with PD
|
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
|
Care Partner
Individuals who are Care Partners of individuals with PD
|
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
|
Health Care Provider
Health Care Providers who provide service to people with PD
|
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Themes of Lived Experience Accessing Health Care Services
Time Frame: 2 hours
|
Inductive and iterative thematic analysis of transcripts
|
2 hours
|
Themes of Lived Experience Providing Health Care Services to LGBTQ+ people with PD
Time Frame: 2 hours
|
Inductive and iterative thematic analysis of transcripts
|
2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tara L McIsaac, PT, PhD, Creighton University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003114-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Individual interviews
-
Centre Hospitalier Universitaire de NīmesNot yet recruiting
-
Centre Hospitalier Universitaire de BesanconUnknown
-
Centre Hospitalier Universitaire de Saint EtienneEcole des Mines Saint-Etienne; Senior AutonomieCompleted
-
Centre Hospitalier Universitaire de Saint EtienneGerontopole Auvergne Rhone-Alpes (AURA); Ecole des Mines de Saint-EtienneCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedUnexplained Chronic Pain | School BullyingFrance
-
Assistance Publique - Hôpitaux de ParisGrégory Lemarchal AssociationCompleted
-
Hospices Civils de LyonRecruiting
-
Pontificia Universidad Catolica de ChileCompleted
-
Azienda Unità Sanitaria Locale di PiacenzaRecruitingQuality of LifeItaly
-
Centre Hospitalier Universitaire de Saint EtienneGerontopole Auvergne Rhone-Alpes (AURA); Ecole des Mines de Saint-Etienne; Eovi...Completed